India  /  Published 09.02.21

India orders 10 million new doses of Covishield

The government has placed orders for one crore additional doses of Covishield from Serum Institute of India and 45 lakh more doses of Covaxin from Bharat Biotech, officials of the two vaccine makers s...
By Our Bureau and Agencies in New Delhi

World  /  Published 06.02.21

Astra data proves ‘jab effective in elderly’

British regulators have received extra trial data from AstraZeneca that supports their view that the Covid-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official ...
By Reuters in London

Opinion  /  Published 06.02.21

Vaccine conspiracy, a new strain, has gone global

A health official telephoned within hours of my first anti-Covid-19 jab and asked if everything was alright. One reason could have been the controversy over the German and French insistence — wh...
By Sunanda K. Datta-Ray in

World  /  Published 04.02.21

Astra vaccine cuts virus transmission

The vaccine developed by the University of Oxford and AstraZeneca not only protects people from serious illness and death but also substantially slows the transmission of the virus, according to a new...
By NYTNS in New York

World  /  Published 30.01.21

EU approves Astra-Oxford vaccine

Europe’s medicine regulator on Friday approved the AstraZeneca and Oxford University’s Covid-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the EU. &...
By Reuters in London


World  /  Published 29.01.21

Germany to limit Astra vaccine

AstraZeneca’s Covid-19 vaccine should only be given to people aged between 18 and 64, Germany’s vaccine committee recommended on Thursday, a day ahead of a decision by European regulators ...
By Reuters in Berlin

World  /  Published 28.01.21

UK minorities urged to take vaccine

On a day when Britain marked a grim milestone with the Covid death toll crossing the 100,000 barrier, Asian and black celebrities put out a video urging members of the ethnic minorities not to listen ...
By Amit Roy in London

India  /  Published 13.01.21

No choice between two vaccines initially

India’s Covid-19 vaccination campaign starting on January 16 with the AstraZeneca-Oxford vaccine and the homegrown Bharat Biotech jab will not offer beneficiaries the option to choose between th...
By G.S. Mudur in New Delhi

Opinion  /  Published 06.01.21

New hope: India ready for Covid vaccines

Sir — It is heartening to note that India is ready to use two coronavirus vaccines for emergency cases. The Oxford-AstraZeneca vaccine, Covishield, made in this country by the Serum Institute of...
By The Telegraph in

Opinion  /  Published 06.01.21

Unclear shot: India vaccine roll out

Rolling out vaccines in the time of a raging pandemic in a nation as populous as India was bound to be accompanied by attendant challenges. But the lack of transparency and public anxiety regarding th...
By The Editorial Board in


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.